<DOC>
	<DOCNO>NCT02336555</DOCNO>
	<brief_summary>This study aim determine whether MK-8291 effective reduce pain participant post-herpetic neuralgia ( PHN ) allodynia . The primary hypothesis compare placebo , treatment MK-8291 reduces change baseline participant-reported pain intensity 1 11-point numeric rating scale .</brief_summary>
	<brief_title>The Efficacy MK-8291 Participants With Post-herpetic Neuralgia ( PHN ) With Allodynia ( MK-8291-012 )</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<criteria>nonpregnant female ( and/or partner ) agree use two acceptable method birth control throughout trial 2 week last dose treatment female postmenopausal surgically sterile clinical diagnosis PHN allodynia least 3 month duration heal rash body mass index ( BMI ) = &lt; 35 kg/m^2 , inclusive good health , exception PHN stable dose least 30 day prior screen follow : opioids , nonopioids , paracetomol , nonsteroidal antiinflammatory drug ( NSAIDs ) , aspirin , antidepressant nonsmoker use nicotine nicotine containing product least prior 3 month nonPHN chronic pain state history clinically significant inadequately treated endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary , major neurological ( include stroke chronic seizure ) abnormality diseases history malignant cancer history presence esophagitis history significant multiple and/or severe allergy ( e.g . food , drug , latex ) , anaphylactic reaction significant intolerability prescription nonprescription drug food positive hepatitis B surface antigen , hepatitis C antibody , human immunodeficiency virus ( HIV ) major surgery , donate lose approximately 500 mL blood within 4 week prior screen participate another investigational trial within 4 week prior screen history risk factor Torsades de Pointes , hypokalemia hypomagnesemia history presence clinically significant cardiac arrhythmia , take substance target reduce heart rate exercise endurance sport injection local anesthetic steroid region affect PHN , within 35 day prior randomization anticipates use prescription nonprescription drug herbal remedy trial consumes excessive amount alcoholic caffeinated beverage use cannabis , illicit drug , history drug ( include alcohol ) abuse within 12 month screen visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>